Because GLP-1s slow the rate at which you digest fat, food stays in the stomach longer, and may be more likely to cause acid reflux and nausea and vomiting, says Dureiko
Remember, healthy skin is about more than just appearance
The two peptides differ on every axis that matters for protocol design: origin, structural class, mechanism, the repair-cascade window they appear to act on, and the strength of the underlying evidence
In the REDEFINE 1 phase 3 trial (NCT05567796), which enrolled adults with overweight or obesity (BMI 27 kg/m) and at least 1 weight-related comorbidity but without type 2 diabetes, participants receiving CagriSema (cagrilintide 2.4 mg + semaglutide 2.4 mg) achieved a mean body weight reduction of 22.7% from baseline after 68 weeks among adherent participants, compared with approximately 3% in the placebo group.5 These results establish CagriSema as one of the most potent antiobesity therapies investigated to date
Conservative practice suggests using each vial within two to four weeks
Traumeel an emerging option to nonsteroidal anti-inflammatory drugs in the management of acute musculoskeletal injuries